Barry Bohlen, MD
Orthopaedic Surgery · Hastings, NENPI 1710928130
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (38.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Arthrex at 55.7% of the total. Reporting peaked in 2021 at $3,412 and has fallen 99.5% since, to $18 in 2024.
Across 65 payments — averaging $102.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Stryker$1K
- Johnson & Johnson$594
- RSW Medical Company, Inc.$412
- Conetic Solutions, Inc.$375
- Medical Device Business Services, Inc.$93
- plus $263 from 11 others
What the payments were for
- Travel & lodging$1,79627%
- Food & beverage$2,28534%
- Education$2,55038%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 22 | $3,697 |
| Stryker | 18 | $1,197 |
| Johnson & Johnson | 5 | $594 |
| RSW Medical Company, Inc. | 1 | $412 |
| Conetic Solutions, Inc. | 3 | $375 |
| Medical Device Business Services, Inc. | 3 | $93 |
| Innovation Technologies Inc | 1 | $69 |
| Heron Therapeutics, Inc. | 2 | $35 |
| Bioventus LLC | 2 | $32 |
| Linvatec Corporation | 1 | $24 |
| Sonex Health, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $17 |
| Zimmer Biomet | 1 | $16 |
| KCI USA, Inc. | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $13 |
| Pacira Therapeutics, Inc. | 1 | $13 |
| Medtronic | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Velys$537
- MAKO$391
- PRIME SERIES$106
How this compares
$6,631 in reported general payments places this provider in the 65th percentile of 155 orthopaedic surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 61 | $239 |
| Cephalexin | 47 | $204 |
| Meloxicam | 34 | $203 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Hastings
- Eric HeidemannHastings$28K
- Brent HoodHastings$11K
- Todd SekundiakElkhorn$7.3M
- Heber CrockettKearney$4.2M
- Edward FehringerOmaha$2M
- John WrightKearney$1.2M
- Joshua UrbanOmaha$475K
- Sayfe JassimOmaha$460K
- Beau KildowOmaha$353K
- David HuebnerKearney$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.